Vol 9 No 2 (2024): December
Medicine

Gender Age Disparity in Amoebiasis Prevalence in Iraq
Perbedaan Usia Jenis Kelamin dalam Prevalensi Amoebiasis di Irak


Qasim Ibrahim Khalaf
Ministry of Education, Center of Research and Educational Studies, Iraq *

(*) Corresponding Author
Picture in here are illustration from public domain image or provided by the author, as part of their works
Published June 7, 2024
Keywords
  • Amoebiasis,
  • Entamoeba Histolytica,
  • Prevalence,
  • Gender Disparity
How to Cite
Khalaf, Q. I. (2024). Gender Age Disparity in Amoebiasis Prevalence in Iraq. Academia Open, 9(2), 10.21070/acopen.9.2024.9104. https://doi.org/10.21070/acopen.9.2024.9104

Abstract

This comparative cross-sectional study evaluates the prevalence of Entamoeba histolytica, the causative agent of amoebiasis, in the human population of Diyala Governorate, conducted at Alshams Medical Labs in Baqubah city. Despite the global health burden of amoebiasis, particularly in developing countries, data on its age and gender-specific prevalence remain sparse. Aimed at filling this knowledge gap, our research specifically assessed the distribution of E. histolytica in males and females across two age groups (1-15 years and 15-45 years). The study found that 74% of females aged 1-15 years harbored both cysts and trophozoites, while males of the same age group showed a markedly lower prevalence at 19%. In the 15-45 year age group, males demonstrated a higher prevalence (50%) compared to females (9%). These findings suggest significant gender and age-related disparities in the prevalence of E. histolytica. The results could inform targeted public health interventions and contribute to more effective management and prevention strategies for amoebiasis in endemic regions.

Highlights:

  • Gender Disparity: Marked differences in infection rates between males and females.
  • Age Influence: Varied prevalence across different age groups.
  • Health Strategy Needs: Highlights the necessity for targeted public health interventions.

Keywords: Amoebiasis, Entamoeba Histolytica, Prevalence, Gender Disparity

Downloads

Download data is not yet available.

References

  1. M. Kantor, A. Abrantes, A. Estevez, A. Schiller, J. Torrent, J. Gascon, and C. Ochner, "Entamoeba Histolytica: Updates in Clinical Manifestation, Pathogenesis, and Vaccine Development," Canadian Journal of Gastroenterology and Hepatology, vol. 2018, 2018.
  2. N. A. El-Dib, "Entamoeba Histolytica: An Overview," Current Tropical Medicine Reports, vol. 4, pp. 11-20, 2017.
  3. D. A. Shirley, C. C. Hung, and S. Moonah, "Entamoeba Histolytica (Amebiasis)," in Hunter's Tropical Medicine and Emerging Infectious Diseases, Elsevier, pp. 699-706, 2020.
  4. T. Tharmaratnam, T. Kumanan, M. A. Iskandar, K. D’Urzo, P. Gopee-Ramanan, M. Loganathan, and I. Tobbia, "Entamoeba Histolytica and Amoebic Liver Abscess in Northern Sri Lanka: A Public Health Problem," Tropical Medicine and Health, vol. 48, no. 1, 2020.
  5. H. Y. Kadhem, E. M. Hamad, and A. Abdulameer, "The Prevalence of Entamoeba Histolytica Infection in Iraqi Infants and Children with Diarrhea in Diyala Province with Unusual Presentation," NeuroQuantology, vol. 20, no. 12, pp. 2610, 2022.
  6. F. H. O. Al-Khikani, R. M. Hameed, and A. S. Ayit, "Prevalence of Entamoeba Histolytica and Giardia Lamblia Associated with Infectious Diarrhea in Al-Shomally Population, Babil, Iraq," Biomedical and Biotechnology Research Journal (BBRJ), vol. 3, no. 4, pp. 245-248, 2019.